Search
for
Sort by
Research 301–330 of 1000+
- Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation
- LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- Serum Level of Survivin in Patients with Alopecia Areata and its Association with Disease Severity and Progression
- Vitamin D And Tmprss2: Intersecting Pathways In Post-Covid-19 Alopecia
- Advances in the mechanism and new therapies of alopecia areata
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- 148 Decreased IL-10 producing regulatory B cells in patients with alopecia areata
- Viewpoint 3
- MicroRNA in skin diseases
- Novel therapies for alopecia areata: The era of rational drug development
- Current and future pharmacotherapy for alopecia areata
- Alopecia Areata: A tissue specific autoimmune disease of the hair follicle
- IL-15 in T-Cell Responses and Immunopathogenesis
- Deciphering the functions of the hair follicle infundibulum in skin physiology and disease
- Global behavior of solutions in a chemotaxis model for alopecia areata with signal-dependent sensitivity
- Immune Regulation in Hair Follicle Protection and Hair Regeneration: Insights from the Collapse of Immune Privilege in Alopecia Areata and Targeted Immunotherapy
- The investigation of selective sphingosine-1 phosphate receptor 1&4 modulator to treat alopecia areata mouse model 2881
- ISIDLB1777 - A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- 1432 IL-9/IL-9R signaling as a novel regulator of human hair follicle growth and immune privilege
- Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- 1419 Pre-clinical in-vitro assays for high throughput screening of drug candidates for protection and restoration of immune privilege in alopecia areata
- Professor Han Shirong's Dialectical Analysis of the Experience of Treating Spot Baldness
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Advancements and challenges in stem cell transplantation for regenerative medicine
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis
- Combined Alopecia Areata and Acquired Hypertrichosis Lanuginosa in Celiac Disease- A Rarest Phenomenon
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases